Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction

American Journal of Cardiology

Volumn 92, Issue 8, 2003, Pages 913-918

  Karha, Juhana ^b   Murphy, Sabina A ^b   Kirtane, Ajay J ^b   De Lemos, James A ^b   Aroesty, Julian M ^b   Cannon, Christopher P ^b   Antman, Elliott M ^b   Braunwald, Eugene ^b   Gibson, C Michael ^a  

^a TIMI Data Coordinating Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALTEPLASE; ANISTREPLASE; RETEPLASE; TENECTEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; EVALUATION; FEMALE; HUMAN; INCIDENCE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SURVIVAL; TREATMENT OUTCOME;

EID: 0141594933     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00969-X     Document Type: Article

References (20)

1. Gibson C.M., Murphy S.A., Rizzo M.J., Ryan K.A., Marble S.J., McCabe C.H., Cannon C.P., Van de Werf F., Braunwald E. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation. 99:1999;1945-1950.
2. Lundergan C.F., Reiner J.S., McCarthy W.S., Coyne K.S., Califf R.M., Ross A.M. Clinical predictors of early infarct-related artery patency following thrombolytic therapy importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: The GUSTO-I experience. J Am Coll Cardiol. 32:1998;641-647.
3. Muller D.W.M., Topol E.J., Ellis S.G., Sigmon K.N., Lee K., Califf R.M. Multivessel coronary artery disease a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction . Am Heart J. 121:1991;1042-1049.
4. Cannon C.P., McCabe C.H., Diver D.J., Herson S., Greene R.M., Shah P.K., Sequeira R.F., Leya F., Kirshenbaum J.M., Magorien R.D., et al. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial . J Am Coll Cardiol. 24:1994;1602-1610.
5. Cannon C.P., McCabe C.H., Gibson C.M., Ghali M., Sequeira R.F., McKendall G.R., Breed J., Modi N.B., Fox N.L., Tracy R.P., Love T.W., Braunwald E. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. Circulation. 95:1997;351-356.
6. Cannon C.P., Gibson C.M., McCabe C.H., Adgey A.A., Schweiger M.J., Sequeira R.F., Grollier G., Giugliano R.P., Frey M., Mueller H.S., et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators . Circulation. 98:1998;2805-2814.
7. Antman E.M., Giugliano R.P., Gibson C.M., McCabe C.H., Coussement P., Kleiman N.S., Vahanian A., Adgey A.A., Menown I., Rupprecht H.J., et al. Abciximab facilitates the rate and extent of thrombolysis results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators . Circulation. 99:1999;2720-2732.
8. Antman E.M., Gibson C.M., de Lemos J.A., Giugliano R.P., McCabe C.H., Coussement P., Menown I., Nienaber C.A., Rehders T.C., Frey M.J., et al. Combination reperfusion therapy with abciximab and reduced dose reteplase results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators . Eur Heart J. 21:2000;1944-1953.
9. Gibson C.M., Ryan K., Sparano A., Moynihan J.L., Rizzo M., Kelley M., Marble S.J., Laham R., Simons M., McClusky T.R., Dodge J.T. Jr. Angiographic methods to assess human coronary angiogenesis. Am Heart J. 137:1999;169-179.
10. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 312:1985;932-936.
11. Gibson C.M., Cannon C.P., Daley W.L., Dodge J.T. Jr, Alexander B. Jr, Marble S.J., McCabe C.H., Raymond L., Fortin T., Poole W.K., Braunwald E. TIMI frame count a quantitative method of assessing coronary artery flow . Circulation. 93:1996;879-888.
12. Dotani I., Dodge J.T., Goel M., Al-Mousa E.N., McLean C., Rizzo M.J., Ryan K., Vatner R., Marble S.J., Daley W.L., Gibson C.M. New techniques in the angiographic analysis of coronary flow. J Intervent Cardiol. 9:1996;429-444.
13. Gibson C.M., Sandor T., Stone P.H., Pasternak R.C., Rosner B., Sacks F.M. Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol. 69:1992;1286-1290.
14. Gibson C.M., Dodge J.T. Jr, Goel M., Al-Mousa E.N., Rizzo M., McLean C., Ryan K., Sparano A., Marble S.J., Daley W.L., Cannon C.P., Antman E.M. Angioplasty guidewire velocity a new simple method to calculate absolute coronary blood velocity and flow . Am J Cardiol. 80:1997;1536-1539.
15. Dodge J.T. Jr, Brown B.G., Bolson E.L., Dodge H.T. Intrathoracic spatial location of specified coronary segments on the normal human heart. Applications in quantitative arteriography, assessment of regional risk and contraction, and anatomic display. Circulation. 78:1988;1167-1180.
16. StataCorp. Stata Statistical Software. Release 5.0. College Station, Texas: Stata Corporation, 1997.
17. Bates E.R., Califf R.M., Stack R.S., Aronson L., George B.S., Candela R.J., Kereiakes D.J., Abbottsmith C.W., Anderson L., Pitt B., O'Neill W.W., Topol E.J. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial influence of infarct location on arterial patency, left ventricular function and mortality . J Am Coll Cardiol. 13:1989;12-18.
18. Hillis L.D., Askenazi J., Braunwald E., Radvany P., Muller J.E., Fishbein M.C., Maroko P.R. Use of changes in the epicardial QRS complex to assess interventions which modify the extent of myocardial necrosis following coronary artery occlusion. Circulation. 54:1976;591-598.
19. Askenazi J., Maroko P.R., Lesch M., Braunwald E. Usefulness of ST segment elevations as predictors of electrocardiographic signs of necrosis in patients with acute myocardial infarction. Br Heart J. 39:1977;764-770.
20. Muller J.E., Maroko P.R., Braunwald E. Evaluation of precordial electrocardiographic mapping as a means of assessing changes in myocardial ischemic injury. Circulation. 52:1975;16-27.